Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001915900 | SCV002178447 | likely benign | not provided | 2024-10-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002331430 | SCV002633158 | uncertain significance | Inborn genetic diseases | 2018-02-08 | criteria provided, single submitter | clinical testing | The p.R1449Q variant (also known as c.4346G>A), located in coding exon 1 of the RAI1 gene, results from a G to A substitution at nucleotide position 4346. The arginine at codon 1449 is replaced by glutamine, an amino acid with highly similar properties. This variant did not co-segregate with disease in one individual tested in our laboratory. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Prevention |
RCV004743640 | SCV005347584 | uncertain significance | RAI1-related disorder | 2024-09-13 | no assertion criteria provided | clinical testing | The RAI1 c.4346G>A variant is predicted to result in the amino acid substitution p.Arg1449Gln. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.013% of alleles in individuals of African descent in gnomAD. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |